What is STATKING Consulting?
STATKING Clinical Services operates as a fully integrated contract research organization (CRO), dedicated to advancing drug discovery from initial target identification through to IND filing. The company also expertly manages Phase I-III clinical trials. Their comprehensive service portfolio includes clinical trial management, biostatistics, clinical data management, medical writing, and specialized statistical consulting. With deep expertise across therapeutic areas such as oncology, CNS, diagnostics, and orphan drug development, STATKING provides tailored solutions for pharmaceutical and medical device industries, supporting both drug and biologic development as well as medical devices.
How much funding has STATKING Consulting raised?
STATKING Consulting has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in STATKING Consulting
PPP
Public-Private Partnership
What's next for STATKING Consulting?
The substantial large-scale, late-stage funding indicates STATKING Consulting is poised for significant expansion and strategic initiatives. This capital injection is likely to fuel further development of their integrated CRO services, potentially through acquisitions, enhanced technological capabilities, or broader market penetration. The company's focus on critical phases of drug development and clinical trial management positions it to capitalize on ongoing demand within the pharmaceutical and biotech sectors, aiming to accelerate therapeutic advancements.
See full STATKING Consulting company page
